Home › J&J profit rises 13% to $4.3-billion, beats forecast
 

Keywords :   


J&J profit rises 13% to $4.3-billion, beats forecast

2014-07-16 02:07:36| Biotech - Topix.net

Johnson & Johnson reported higher-than-expected quarterly revenue and earnings, benefiting from strong sales of its Olysio treatment for hepatitis C. The diversified healthcare company on Tuesday said it had earned $4.33-billion, or $1.51 per share, in the second quarter.

Tags: profit forecast beats rises

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Digital video subscriptions to reach 3.5 billion by 2028
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
More »